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Abstract 
In this work the corresponding 4-amino-6-pyridyl-2-phenyl-5-carbethoxypyrimidine (3) was synthesized through 
a one-pot, three-component reaction of pyridine-3-carbaldehyde, ethyl cyanoacetate and benzamidine 
hydrochloride in the presence of TEA in refluxing ethanol-DMF mixture. The synthesized pyrimidine (3) was 
directly transformed to medicinally important pyrimido[4,5-d]pyrimidine derivatives. All the synthesized 
products were tested and evaluated as antimicrobial agents.      
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1. Introduction 
Pyrimido pyrimidines are annelated uracils that have attracted considerable interest in recent years. Derivatives 
of pyrimido pyrimidine are known to display a wide range of pharmacological activities, and their potent 
inhibitory properties regarding the tyrosine kinase domain of epidermal growth factor receptor (Rewcastle et al. 
1997), 5-phosphoribosyl-1-pyrophosphate synthetase (Fry et al. 1995) and dihydrofolate reductase (Gready et al. 
2003) have been fully demonstrated. Numerous reports delineate the antitumor (Sanghhvi et al. 1989), antiviral 
(Tenser et al. 2001), antioxidant (De la Cruz et al. 1992), antifungal and heptatoprotective activities (Ram et al. 
2002). Combinatorial chemistry is playing an increasingly important role as one of the tool of modern medicinal 
chemistry for the rapid discovery of new leads (Gordan et al. 1994; Virgilio & Ellman 1994; Freier et al. 1995; 
Gordeev et al. 1997). Multi-component reactions (MCRs) (Zhu & Bienayme 2005; Domling 2006; Ram et al. 
2002) are masterpieces of synthetic efficiency and reaction design. Inevitably, many classical heterocyclic 
syntheses are MCR that are based upon carbonyl group condensations. Hence, medicinal chemistry is largely 
found on these easily accessible heterocyclic frameworks. The use of multicomponent reactions (MCRs) to 
generate interesting and novel, druglike scaffolds is replete in the recent chemical literature (Ugi et al. 1997; 
Armstrong et al. 1996). This prompted us to synthesize some new pyrimido-pyrimidine derivatives starting from 
4-amino-5-carbethoxy pyrimidine derivative 3 which prepared as shown in Scheme 1. 
 
 
Scheme 1. Synthesis of 4-amino-6-pyridyl-2-phenyl-5-carbethoxypyrimidine (3) 
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2. Results and discussion 
2.1. Chemistry 
Initially, pyridine-3-carboxaldehyde 1, ethyl cyanoacetate and benzamidine hydrochloride 2, were mixed and 
heated in ethanol-DMF (1:1) in presence of a catalytic amount of TEA. The product 3 was prepared with 
excellent yield. The IR spectrum showed bands at 3500-3400 (NH2), 3100 (NH), 1690 (CO), 1595 cm-1 (C=C), 
1HNMR spectrum showed peaks at δ 1.09 (CH3), 4.30 (CH2), 6.90 (NH2) and 7.50-8.36 (m, Ar-H). 
Fusion of 3 with 2-amino pyridine in the presence of a catalytic amount of freshly fused sodium acetate afforded 
the amide derivative (4) whose IR spectrum showed bands at 3500-3400 (NH2), 3100 (NH), 1680 (C=O), 1595 
cm-1 (C=C). 
This amide reacted with chloroacetyl chloride in chloroform at room temperature to give the chloro-acetylamino 
derivative (5), the structure of which was supported by IR spectrum showing bands at 3100 (NH), 1680 (C=O), 
1687 (C=O), 1595 (C=C) and 760 cm-1 (C-Cl), and PMR spectrum exhibiting a proton singlet at δ 4.27 (CH2) in 
addition to a multiplet due to aromatic and NH protons. 
The chloroacetylamino derivative (5) was cyclized by refluxing with acetic anhydride to give the corresponding 
pyrimidine derivative (6). Its structure was established on the basis of elemental analysis and spectral data. The 
IR spectrum showed bands at 2950 (C-H methylene), 1700 (C=O), 1595 (C=C) and 760 cm-1 (C-Cl), while PMR 
spectrum exhibited two-protons singlet at δ 4.37 (CH2). 
The Mannich base moiety is known to have diverse pharmacological properties including antibacterial, antiviral, 
and antiallergic. This prompted us to synthesis pyrimidine derivatives possessing a Mannich base moiety. Thus, 
the chloro compound 6 and an appropriate secondary amine when left at room temperature for several days gave 
the corresponding Mannich base (7a,b) (Scheme 2). 
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Scheme 2. Synthesis of pyrido[4,3-d]pyrimidine derivatives 6 and 7 
The IR spectra of 7 displayed bands around 1565,1620 and 2900 cm-1 assignable to C-N, C=N and CH2 
stretching, respectively. The PMR spectrum of VIIa in CDCl3 exhibited signals at δ 3.91 (s, 2H, -C-CH2-N), 3.18 
[s, 6H, (NMe)2], and 7.50-8.30 (m, 12H, Ar-H). The PMR data of the other member 7b of the series were also in 
agreement with its structure.  
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In continuation of our study on various reactions (Mohamed et al. 2013; Fadda et al. 2008; Fadda & Abdel-
Razek 2001; Fadda 2012), we report herein the results of our investigation on the reaction of 3 with 2-
nitrophenoxyacetic acid (9). It was found that the amino acid 8, obtained by hydrolysis of the aminoester 3, 
reacted with 9 to give the corresponding oxazine 10 (Scheme 3). Its IR spectrum showed bands at 1680 (C=O), 
1520, 1360 cm-1 aromatic (NO2). 
 
Scheme 3. Synthesis of pyrimido-oxazinone derivatives 10 and 12 
The oxazine derivative 10 on reduction afforded a product which was assigned the structure 12 based on 
elemental analysis and spectral data. The formation of 12 may be assumed to proceed as shown in Scheme 3. 
Attempts to isolate the intermediate 11 remained unsuccessful. Absence of IR bands at 1360 and 1525 cm-1 due 
to the aromatic nitro group, present in its precursor, indicated that the reduction of nitro group was complete and 
also the absence of 3300-3400 cm-1 band confirmed that the amino group formed during this reduction had 
reacted interamolecularly with oxazine oxygen to form 12. 
Reaction of the amino acid 8 with acetic anhydride seemed to be a logical method for the preparation of the 
corresponding oxazine derivative. Such a reaction furnished 2-methyl-7-phenyl-5-(pyridin-3-yl)-4H-
pyrimido[4,5-d][1,3]oxazin-4-one (13) (Scheme 4). 
We also report herein the synthesis of new pyrimido-pyrimidines (14) via the reaction of 13 with hydrazine 
hydrate and aromatic amines. The IR spectrum of 14a showed bands at 3400-3350 (NH2), 2950 (CH3), 1680 cm-1 
(C=O). The pyrimido-pyrimidines 14a,b were reacted with benzaldehyde to give the corresponding Schiff base 
(15a) and the arylidene derivative (15b), respectively (Scheme 4). 
Compound 15a showed IR peaks at 1690 ( ) and 1610 cm-1 (C=N), whereas compound 15b gave 
peaks at 1680 (C=O) and 1590 cm-1 (C=C). The PMR spectrum of 15a exhibited signals at δ 2.3 (s, 3H, CH3), 
7.50-8.35 (m, 13H, Ar-H) and one azomethine proton at δ 9.01 ppm, whereas that of 15b showed signals at 5.3 
(d, 1H, CH=CH, J = 7.4 Hz), 6.2 (d, 1H, -CH=CH-, J = 7.4 Hz) and 7.50-8.33 (m, 13H, Ar-H). From the J values 
of CH-CH protons we can say that these protons are cis-oriented.  
The pyrimido amino ester 3 also reacted with formamide to yield the corresponding pyrimido-pyrimidine (16) 
which formed the Mannish base 17 (Scheme 4). The IR spectrum of 17 displayed bands around 1565,  
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Scheme 4. Synthesis of pyrimido[4,5-d]pyrimidine derivatives 14-17 
 
1622, 1681 and 2900 cm-1 assignable to C-N, C=N, C=O and CH2 stretching, respectively. The PMR spectrum of 
17a in DMSO exhibited signals at δ 3.18 [s, 6H, -N(Me)2], 4.31 (s, 2H, -N-CH2-N), , 7.48-8.57 (m, 8H, 10 Ar-H), 
9.23 (s, 1H, C2-H pyridine), 9.44 (s, 1H, N=CH). 
Recently, activated nitriles have been used for the synthesis of a large variety of heterocyclic compounds (Fadda 
et al. 2013; Fadda et al. 2013; Fadda et al. 2012; Fadda et al. 2007; Fadda et al. 2006; Fadda et al. 2003). This 
prompted us to synthesize some new pyrimido-pyrimidine derivatives via the reaction of 3 with different 
activated nitriles. 
Thus, fusion of 3 with ethyl cyanoacetate in an oil-bath afforded the pyrimido-pyrimidine derivative 18. The 
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structure assignment of which was based on both elemental and spectral data. The IR spectrum showed 
absorption bands at 3500 (OH), 1720 cm-1 (CO). 1HNMR spectrum showed signals at δ 1.2 for CH3 protons, 4.1 
CH2 protons and 4.2 for CH2CH3 protons. In addition, when 3 was treated with trichloroacetonitrile in refluxing 
ethanol afforded the corresponding pyrimido-pyrimidine 19.  
 
Fig 1.: Structures of pyrimido[4,5-d]pyrimidine derivatives 18-20 
2.2. Antimicrobial evaluation 
Twenty one of newly synthesized target compounds were evaluated for their in vitro antibacterial activity against 
Bacillus subtilis and Bacillus thuringiensis as example of Gram positive bacteria and Escherichia coli and 
Pseudomonas aeruginosa as examples of Gram-negative bacteria. They were also evaluated for their in vitro 
antifungal potential against Fusarium oxysporum and Botrytis fabae fungal strains. 
Agar-diffusion method was used for the determination of the preliminary antibacterial and antifungal activity. 
Chloramphenicol, cephalothin and cycloheximide were used as reference drugs. The results were recorded for 
each tested compound as the average diameter of inhibition zones (IZ) of bacterial or fungal growth around the 
disks in mm. The minimum inhibitory concentration (MIN) measurement was determined for compounds 
showed significant growth inhibition zones (> 14 mm) using two fold serial dilution method (Fadda et al. 2013). 
The MIC (µg/mL) and inhibition zone diameters values are recorded in Table 1.  
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Table 1: Minimal inhibitory concentration (MIC, µg/mL) and inhibition zone (mm) of some new synthesized 
compounds  
Compound No. 
MICa in µg/mL, and inhibition zone (mm) 
Bacteria Fungi 
Gram-positive bacteria Gram-negative bacteria 
B. subtilis B. thuringiensis E. coli P. aeruginosa F. oxysporum B. fabae 
3 
4 
5 
6 
7a 
7b 
8 
9 
10 
12 
13 
14a 
14b 
15a 
15b 
16 
17a 
17b 
18 
19 
20 
Chloramphenicol 
Cephalothin       
Cycloheximide 
50 (18) 
25 (27) 
6.25 (45) 
6.25 (33) 
3.125 (32) 
3.125 (44) 
12.5 (32) 
12.5 (32) 
6.25 (38) 
12.5 (32) 
6.25 (37) 
6.25 (38) 
6.25 (38) 
3.125 (40) 
3.125 (41) 
25 (26) 
3.125 (44) 
3.125 (40) 
25 (27) 
12.5 (32) 
3.125 (40) 
3.125 (44) 
6.25 (36) 
NT 
50 (14) 
50 (15) 
6.25 (38) 
6.25 (37) 
6.25 (20) 
6.25 (37) 
50 (20) 
50 (15) 
6.25 (30) 
6.25 (38) 
6.25 (37) 
6.25 (37) 
6.25 (37) 
6.25 (37) 
6.25 (38) 
12.5 (44) 
6.25 (38) 
6.25 (37) 
50 (20) 
12.5 (44) 
6.25 (37) 
3.125 (44) 
6.25 (37) 
NT 
100 (15) 
100 (15) 
25 (25) 
50 (20) 
100 (15) 
100 (14) 
100 (15) 
100 (15) 
100 (14) 
100 (15) 
100 (15) 
100 (15) 
100 (15) 
100 (15) 
100 (15) 
50 (20) 
100 (15) 
25 (25) 
100 (15) 
6.25 (37) 
6.25 (37) 
6.25 (37) 
6.25 (38) 
NT 
50 (19) 
100 (16) 
12.5 (33) 
50 (19) 
100 (15) 
50 (20) 
100 (15) 
100 (16) 
100 (15) 
50 (19) 
100 (15) 
50 (19) 
50 (19) 
50 (19) 
50 (19) 
50 (19) 
100 (16) 
12.5 (33) 
100 (16) 
50 (19) 
50 (19) 
6.25 (38) 
6.25 (37) 
NT 
100 (16) 
50 (19) 
100 (16) 
12.5 (33) 
12.5 (25) 
12.5 (38) 
25 (25) 
50 (19) 
100 (16) 
100 (15) 
12.5 (33) 
100 (15) 
100 (15) 
100 (15) 
100 (15) 
100 (15) 
12.5 (33) 
12.5 (33) 
100 (15) 
50 (19) 
100 (16) 
NT 
NT 
3.125 (43) 
50 (18) 
100 (16) 
25 (27) 
50 (20) 
6.25 (16) 
6.25 (19) 
100 (16) 
50 (20) 
100 (16) 
100 (15) 
12.5 (32) 
100 (16) 
100 (16) 
100 (16) 
100 (16) 
50 (20) 
100 (15) 
50 (20) 
100 (15) 
100 (16) 
100 (15) 
NT 
NT 
3.125 (42) 
 
MIC: Minimal inhibitory concentration values with SEM = 0.02. NT: Not tested.  
 
The results depicted in Table 1 revealed that the most of tested compounds displayed variable inhibitory effects 
on the growth of the tested Gram-positive and Gram negative bacterial strains, and also against antifungal strain. 
In general most of the tested compounds revealed better activity against the Gram-positive rather than the Gram-
negative bacteria. 
Regarding the structure-activity relationship of the pyrimido pyrimidine derivatives against Gram positive 
bacteria, the results revealed that compounds 5, 6, 7a,b, 17a,b, and 20 exhibited broad spectrum antibacterial 
profile against the tested organisms. Mannish base derivatives 7a,b and XVII recorded higher activity than the 
other pyrimido pyrimidine dervatives. In this view, compounds 17a,b and 20 were equipotent to 
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chloramphenicol in inhibiting the growth of B. subtilis (MIC 3.125 µg/mL), while its activity was 50% lower 
than of chloramphenicol against B. thuringiensis. Compounds 5, 6, 10, 13 and 14a,b  showed 50% of the activity 
of chloramphenicol (MIC 6.25 µg/mL) but they were equipotent to cephalothin in inhibiting the growth of B. 
subtilis and B. thuringiensis (MIC 6.25 µg/mL).  
On the other hand, compounds 3, 4, 8, 10, 12, 13, 14a,b, 16, 18 and 19 exhibited moderate growth inhibitory 
activity against Gram-positive bacteria as revealed from their MIC values (6.25-50 µg/mL). Among these 
compounds 10, 13, 14a and 14b showed good growth inhibitory against B. subtilis (MIC 6.25 µg/mL), while the 
rest of other compounds 8, 9, 12 and 19 showed relatively good growth inhibitory profiles against B. subtilis 
(MIC 12.5 µg/mL) which were about 25% of the activity chloramphenicol and 50% cephalothin against the same 
organism. Concerning the antibacterial activity of the compound 3 revealed weak growth inhibitory against the 
tested Gram-positive bacteria (MIC 50 µg/mL). 
Regarding the activity of Mannish base derivatives, against antifungal strains, the results revealed that compound 
7a,b was 50% lower than cycloheximide in inhibitory the growth of B. fabae (MIC 6.25 µg/mL), while the 
activity of compound 7a,b and 17a,b were 25% lower than cycloheximide against F. oxysporum (MIC 12.5 
µg/mL).  
The tested compounds were more active against Gram-positive than Gram-negative bacteria, it may be 
concluded that the antimicrobial activity of the compounds is related to cell wall structure of the bacteria. It is 
possible because the cell wall is essential to survival of bacteria and some antibiotics are able to kill bacteria by 
inhibiting a step in the synthesis of peptidoglycan. Gram-positive bacteria possess a thick cell wall containing 
many layers of peptidoglycan and teichoic acids, but in contrast, Gram-negative bacteria have a relatively thin 
cell wall consisting of a few layers of peptidoglycan surrounded by a second lipid membrane containing 
lipopolysaccharides and lipoproteins. These differences in cell wall structure can produce differences in 
antibacterial susceptibility and some antibiotics can kill only Gram-positive bacteria and are inactive against 
Gram-negative pathogens (Fadda 2012).  
In conclusion, the objective of the present study was to synthesize and investigate the antimicrobial activities of 
some new functionalized pyrimido pyrimidine and their Mannish base derivatives with the hope of discovering 
new structure leads serving as antimicrobial agents. Our aim has been verified by the synthesis of four different 
rings. 
 
3. Experimental 
3.1. Instruments 
Melting points were measured with a Gallenkamp apparatus and are uncorrected. IR spectra were recorded for 
KBr disc on a Mattson 5000 FTIR spectrophotometer. 1H-NMR and 13C-NMR spectra were measured on a 
Bruker AC 300 (300 MHz) in CDCl3 or DMSO-d6 as solvent, using TMS as an internal standard, and chemical 
shifts are expressed as δppm. Mass spectra were determined on Finnigan Incos 500 (70 ev). Elemental analyses 
were carried out at the Microanalytical Center of Cairo University. All reactions were followed by TLC (Silica 
gel, aluminum sheets 60 F254, Merck. 
3.1.1. Synthesis of ethyl 4-amino-2-phenyl-6-(pyridin-3-yl)pyrimidine-5-carboxylate (3) 
Ethyl cyanoacetate (0.1 mol), pyridine-3-carboxyladehyde (0.1 mol) and benzamidine hydrochloride (0.1 mol), a 
catalytic amount of triethylamine was refluxed in ethanol-DMF (25 ml) for 4 hours. (The reaction was monitored 
by TLC using a mixture of EtOAc and Pet.ether 1:1). The reaction mixture was cooled and the precipitated solid 
material was filtered off and recrystallized from a mixture of ethanol-DMF (1:1) to give ethyl 4-amino-2-phenyl-
6-(pyridin-3-yl)pyrimidine-5-carboxylate (3). 
Yield (72%); m.p. 181 oC; IR (KBr): ν/cm-1= 3500-3400 (NH2), 3100 (NH), 1690 (CO), 1595 (C=C); 1H-NMR 
(DMSO-d6) δ (ppm): 1.09 (t, 3H, CH3), 4.30 (q, 2H, CH2), 6.90 (s, 2H, NH2), 7.57-8.70 (m, 3H, pyridine), 7.50-
8.36 (m, 5H, Ar-H), 9.24 (s, 1H, C2-H pyridine); MS (EI, 70 eV): m/z (%) = 320 (M+, 62). Anal. Calcd. for 
C18H16N4O2 (320.35): C, 67.49; H, 5.03; N, 17.49%. Found: C, 67.31; H, 5.00; N, 17.25%.  
3.1.2. Synthesis of 4-amino-2-phenyl-N-(pyridin-2-yl)-6-(pyridin-3-yl)pyrimidine-5-carboxamide (4) 
A mixture of 2-aminopyridine (0.02 mol) and 3 (0.02 mol) was heated on an oil-bath at 150 °C in the presence of 
sodium acetate (1g) for 2 hr. The solid product, so formed, was washed with water, filtered, dried, and 
crystallized from ethanol. 
Yield (60%); m.p. 221 oC; IR (KBr): ν/cm-1= 3500-3400 (NH2), 3100 (NH), 1680 (CO), 1595 (C=C); 1H-NMR 
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(DMSO-d6) δ (ppm): 6.85 (s, 2H, NH2), 7.19-8.06 (m, 8H, Ar-H), 9.30 (s, 1H, C2-H py), 11.01 (s, 1H, NH); 13C-
NMR (DMSO-d6) δ (ppm): 165 C4-pyrimidine, 164 C=O, 161.0 C2-pyrimidine, 158.0 C6 pyrimidine, 151.0 C2-
NH, 148.0 3C2-pyridine, 138.0 C4-pyridine, 134.0 C4-pyridine, 134.0 C1-ph, 133.0 C3-pyridine, 131.0 C4-
pyridine, 129.0 C3, C5-Ph, 127.0 C2, C6-ph, 124.0 C3-pyridine, 117.9 C3-pyridine, 114.4, 106.8 C3-pyridine; MS 
(EI, 70 eV): m/z (%) = 368 (M+, 72). Anal. Calcd. for C21H16N6O (368.40): C, 68.47; H, 4.38; N, 22.81%. Found: 
C, 68.31; H, 4.11; N, 22.63%. 
3.1.3. Synthesis of 2-chloro-N-(2-phenyl-5-(2-pyridin-2-yl)-acetyl)-6-(pyridin-3-yl) pyrimidin-4-yl)acetamide (5) 
To a solution of 4 (0.005 mol) in chloroform (50 ml), chloroacetyl chloride (0.01 mol) was added and the 
mixture left overnight at room temperature. The reaction mixture was concentrated under reduced pressure and 
cooled to give 5. 
Yield (80%); m.p. 230 oC; IR (KBr): ν/cm-1= 3100 (NH), 1680 (CO), 1687 (CO), 1595 (C=C) and 760 cm-1 (C-
Cl); 1H-NMR (DMSO-d6) δ (ppm): 4.27 (s, 2H, CH2Cl), 7.50-8.30 (m, 5H, Ar-H), 7.57-8.70 (m, 3H, pyridine-H), 
9.21 (s, 1H, C2-H pyridine), 10.60 (s, 1H, NH-CO), 11.30 (s, 1H, NHCO-pyridine); MS (EI, 70 eV): m/z (%) = 
444 (M+, 82). Anal. Calcd. for C23H17ClN6O2 (444.88): C, 62.10; H, 3.85; N, 18.89%. Found: C, 62.00; H, 3.63; 
N, 18.71%. 
3.1.4 Synthesis of 7-(chloromethyl)-2-phenyl-6-(pyridin-2-yl)-4- (pyridin-3-yl)pyrido[4,3-d]pyrimidin-5(6H)-one 
(6) 
A solution of 5. (0.002 mol) in acetic anhydride (10 ml) was refluxed for 6 hr (TLC). The reaction mixture was 
poured over crushed ice and the solid separated was filtered, washed with water and recrystallized from benzene. 
Yield (62%); m.p. 195 oC; IR (KBr): ν/cm-1= 2950 (C-H), 1700 (C=O), 1595 (C=C) and 760 cm-1 (C-Cl); 1H-
NMR (DMSO-d6) δ (ppm): 4.37 (s, 2H, CH2Cl), 7.50-8.30 (m, 5H, Ar-H), 7.51-8.57 (m, 3H, pyridine-H), 9.24 (s, 
1H, C2-H pyridine); MS (EI, 70 eV): m/z (%) = 425 (M+, 29). Anal. Calcd. for C24H16ClN5O (425.87): C, 64.72; 
H, 3.54; N, 19.69%. Found: C, 64.61; H, 3.33; N, 19.50%. 
3.1.5. Synthesis of 7-((N,N-substitutedamino)methyl)-2-phenyl-6- (pyridin-2-yl)-4-(pyridin-3-yl)pyrido[4,3-
d]pyrimidin-5(6H)-one (7a,b) 
General procedure 
A mixture of 6 (0.002 mol) and an appropriate secondary amine (0.0025 mol) was left at room temperature in 25 
ml pyridine for several days. The excess pyridine was distilled off under reduced pressure and the residue poured 
over crushed ice. The crude product was filtered, dried, and recrystallized from ethanol. 
For 7a: Yield (71%); m.p. 231 oC; IR (KBr): ν/cm-1= 2900 (CH2), 1620 (C=N), 1565 (C=C); 1H-NMR (DMSO-
d6) δ (ppm): 3.18 (s, 6H, 2CH3), 3.91 (s, 2H, CH2), 7.50-8.30 (m, 12H, Ar-H), 9.30 (s, 1H, C2-H pyridine); MS 
(EI, 70 eV): m/z (%) = 434 (M+, 82). Anal. Calcd. for C26H22N6O (434.49): C, 68.72; H, 4.86; N, 22.33%. Found: 
C, 68.60; H, 4.70; N, 22.13%. 
For 7b: Yield (63%); m.p. 195 oC, (KBr): ν/cm-1= 1620 (C=N), 1560 (C=C); 1H-NMR (DMSO-d6) δ (ppm): 1.02 
(t, 6H, 2CH3), 2.8 (q, 4H, 2CH2), 3.35 (s, 2H, CH2), 7.50-8.57 (m, 12H, Ar-H), 9.26 (s, 1H, C2-H pyridine); MS 
(EI, 70 eV): m/z (%) = 462 (M+, 15). Anal. Calcd. for C28H26N6O (462.55): C, 69.96; H, 5.44; N, 21.15%. Found: 
C, 69.76; H, 5.31; N, 21.00%. 
3.1.6. Synthesis of 4-amino-2-phenyl-6-(pyridin-3-yl)pyrimidine-5-carboxylic acid (8) 
To a solution of 3 (0.005 mol) in ethanol (5 ml) was added sodium hydroxide (0.5%, 25 ml). The reaction 
mixture was refluxed for 2hr, cooled and neutralized with cold dil. hydrochloric acid. The precipitate was filtered, 
washed with water, dried and recrystallized from methanol. 
Yield (80%); m.p. 187 oC; IR (KBr): ν/cm-1= 3500-3400 (NH2), 1730 (CO); 1H-NMR (DMSO-d6) δ (ppm): 6.89 
(s, 2H, NH2), 7.50-8.70 (m, 8H, Ar-H), 9.25 (s, 1H, C2-H pyridine), 12.75 (s, 1H, COOH); MS (EI, 70 eV): m/z 
(%) = 292 (M+, 78). Anal. Calcd. for C16H12N4O2 (292.29): C, 65.75; H, 4.14; N, 19.17%. Found: C, 65.61; H, 
4.00; N, 19.00%. 
3.1.7. Synthesis of 2-((2-nitrophenoxy)methyl)-7-phenyl-5-(pyridin-3-yl)- 4H-pyrimido[4,5-d][1,3]oxazin-4-one 
(10) 
This compound was prepared following the method reported earlier (Sammour et al. 1973). 
Yield (86%); m.p. 242 oC; IR (KBr): ν/cm-1= 1680 (CO), 1620 (C=N), 1520, 1360 cm-1 (NO2); 1H-NMR 
(DMSO-d6) δ (ppm): 4.79 (s, 2H, CH2-O), 6.84-8.25 (m, 12H, Ar-H), 9.21 (s , 1H, C2-H pyridine); MS (EI, 70 
eV): m/z (%) = 453 (M+, 15). Anal. Calcd. for C24H15N5O5 (453.41): C, 63.58; H, 3.33; N, 15.45%. Found: C, 
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63.33; H, 3.21; N, 15.33%. 
3.1.8. Synthesis of 9-phenyl-11-(pyridine-3-yl)-benzo[b]-pyrimido[4´,5´:4,5] pyrimido[1,2-d][1,4]oxazin-
12(6H)one (12) 
Pyrimidoxazine 10 (0.01 mol) was dissolved in ethanol (20 ml) and Rany nickel (0.5 g) placed into it. Hydrazine 
hydrate (10 ml, 35%) was then carefully added to it at room temperature. After the evolution of hydrogen had 
ceased the reaction mixture was allowed to reflux on a water-bath for 3 hr. It was then acidified with hot 5 N 
hydrochloric acid and filtered hot. The filtrate on cooling yielded the crude product which was recrystallized 
from ethanol. 
Yield (60%); m.p. 261 oC; IR (KBr): ν/cm-1= 1685 (CO), 1620 (C=N); 1H-NMR (DMSO-d6) δ (ppm): 4.80 (s, 
2H, CH2), 7.50-8.70 (m, 12H, Ar-H), 9.24 (s, 1H, C2-H pyridine); 13C-NMR (DMSO-d6) δ (ppm): 2x127, 2x129, 
131, 134 (ph-carbon), 163, 181, 164, 115 pyrimidine, 160, 155, pyrimidone, 76 C-O, 152 O-C, 112, 128, 124, 
115, 119, pyridine 132, 2x147, 124, 134; MS (EI, 70 eV): m/z (%) = 405 (M+, 25). Anal. Calcd. for C24H15N5O2 
(405.42): C, 71.10; H, 3.73; N, 17.27%. Found: C, 70.87; H, 3.55; N, 17.10%. 
3.1.9. Synthesis of 2-methyl-7-phenyl-5-(pyridin-3-yl)-4H-pyrimido[4,5-d][1,3]oxazin-4-one (13) 
It was prepared by following the procedure as described earlier (Zentmeyer & Wanger 1949). 
Yield (68%); m.p. 195 oC; IR (KBr): ν/cm-1= 1690 (CO); 1H-NMR (DMSO-d6) δ (ppm): 1.16 (s, 3H, CH3), 7.50-
8.70 (m, 8H, Ar-H), 9.21 (s, 1H, C2-H pyridine); MS (EI, 70 eV): m/z (%) = 316 (M+, 80). Anal. Calcd. for 
C18H12N4O2 (316.31): C, 68.35; H, 3.82; N, 17.71%. Found: C, 68.10; H, 3.65; N, 17.60%. 
3.1.10. Synthesis of 3-substituted-2-methyl-7-phenyl-5-(pyridin-3-yl) pyrimido[4,5-d]pyrimidin-4(3H)-one 
(14a,b) 
General procedure 
These compounds were synthesized by the well known procedure (Burckhalter & Tendick 1948). 
For 14a:  Yield (81%); m.p. 221 oC; IR (KBr): ν/cm-1= 3400-3350 (NH2); 1680 (CO); 1H-NMR (DMSO-d6) δ 
(ppm): 2.26 (s, 3H, CH3), 5.70 (s, 2H, NH2), 7.50-8.57 (m, 8H, Ar-H), 9.21 (s, 1H, C2-H pyridine); MS (EI, 70 
eV): m/z (%) = 330 (M+, 90). Anal. Calcd. for C18H14N6O (330.35): C, 65.44; H, 4.27; N, 25.44%. Found: C, 
65.31; H, 4.11; N, 25.30%. 
For 14b: Yield (65%); m.p. 241 oC; IR (KBr): ν/cm-1= 1686 (CO); 1H-NMR (DMSO-d6) δ (ppm): 2.21 (s, 3H, 
CH3), 7.50-8.55 (m, 8H, Ar-H), 9.24 (s, 1H, C2-H pyridine); MS (EI, 70 eV): m/z (%) = 391 (M+, 65). Anal. 
Calcd. for C24H17N5O (391.43): C, 73.64; H, 4.38; N, 17.89%. Found: C, 73.38; H, 4.25; N, 17.77%. 
3.1.11. Reaction of benzaldehyde with XIVa,b: Formation of compounds 15a,b 
General procedure (15a,b) 
Benzaldehyde (0.01 mol) and 14 (0.01 mol) in dry abs. ethanol (30 ml) in the presence of piperidine (5 drops) 
were refluxed 3hr. The reaction mixture was concentrated under reduced pressure. The solid product, thus 
obtained, was filtered, dried and recrystallized from ethanol to give 15a,b. 
(Z)3-(Benzylideneamino)-2-methyl-7-phenyl-5-(pyridin-3-yl)pyrimido[4,5-d]pyrimidin-4(3H)-one (15a) 
Yield (82%); m.p. 234 oC; IR (KBr): ν/cm-1= 1690 (CO), 1640 (C=N); 1H-NMR (DMSO-d6) δ (ppm): 2.30 (s, 
3H, CH3), 7.50-8.35 (m, 13H, Ar-H), 9.01 (s, 1H, N=CH), 9.24 (s, 1H, C2-H pyridine); MS (EI, 70 eV): m/z (%) 
= 418 (M+, 15). Anal. Calcd. for C25H18N6O (418.41): C, 71.76; H, 4.34; N, 20.08%. Found: C, 71.63; H, 4.25; N, 
19.77%. 
(E)-3,7-Diphenyl-5-(pyridin-3-yl)-2-styrylpyrimido[4,5-d]pyrimidin-4(3H)-one (15b) 
Yield (73%); m.p. 260 oC; IR (KBr): ν/cm-1= 1680 (CO), 1590 (C=C); 1H-NMR (DMSO-d6) δ (ppm): 5.30 (d, 
1H, CH=C, J = 7.40 Hz), 6.20 (d, 1H, =CH-ph, J = 7.40 Hz), 7.50-8.33 (m, 13H, Ar-H), 9.24 (s, 1H, C2-H 
pyridine); MS (EI, 70 eV): m/z (%) = 479 (M+, 65). Anal. Calcd. for C31H21N5O (479.53): C, 77.64; H, 4.41; N, 
14.60%. Found: C, 77.45; H, 4.33; N, 14.51%. 
3.1.12. Synthesis of 7-phenyl-5-(pyridin-3-yl)pyrimido[4,5-d]pyrimidin-4(3H)-one (16) 
It was obtained according to the literature method (Sherrill et al. 1946). 
Yield (73%); m.p. 213 oC; IR (KBr): ν/cm-1= 3310 (NH), 2900 (C-H), 1680 (CO) 1620 (C=N); 1H-NMR 
(DMSO-d6) δ (ppm): 7.50-8.36 (m, 8H, Ar-H), 9.24 (s, 1H, C2-H pyridine), 9.43 (s, 1H, N=CH), 12.14 (s, 1H, 
NH); MS (EI, 70 eV): m/z (%) = 301 (M+, 100). Anal. Calcd. for C17H11N5O (301.31): C, 67.77; H, 3.68; N, 
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23.24%. Found: C, 67.51; H, 3.41; N, 23.11%. 
3.1.13. Synthesis of 3-((N,N-substitutedamino)methyl) -7-phenyl-5-(pyridin-3-yl)pyrimido [4,5-d]pyrimidin-
4(3H)-one (17a,b) 
These Mannish bases were prepared according to the method as described before for compound 7. 
For 17a: Yield (63%); m.p. 178 oC; IR (KBr): ν/cm-1= 1681 (CO), 1622 (C=N); 1H-NMR (DMSO-d6) δ (ppm): 
3.18 (s, 6H, 2CH3), 4.31 (s, 2H, N-CH2-N), 7.48-8.57 (m, 8H, Ar-H), 9.23 (s, 1H, C2-H pyridine), 9.44 (s, 1H, 
N=CH); MS (EI, 70 eV): m/z (%) = 358 (M+, 100). Anal. Calcd. for C20H18N6O (358.40): C, 67.02; H, 5.06; N, 
23.46%. Found: C, 66.85; H, 4.79; N, 23.22%. 
For 17b: Yield (66%); m.p. 222 oC; IR (KBr): ν/cm-1= 1680 (CO); 1H-NMR (DMSO-d6) δ (ppm): .1.02 (s, 6H, 
2CH3), 2.65 (q, 4H, 2CH2), 4.30 (s, 2H, N- CH2-N), 7.50-8.36 (m, 8H, Ar-H), 9.24 (s, 1H, C2-H pyridine); 9.40 
(s, 1H, N=CH). MS (EI, 70 eV): m/z (%) = 386 (M+, 100). Anal. Calcd. for C22H22N6O (386.46): C, 68.38; H, 
5.74; N, 21.75%. Found: C, 68.12; H, 5.66; N, 21.53%. 
3.1.14. Synthesis of ethyl-2-(4-hydroxy-7-phenyl-5- (pyridine-3-yl)pyrimido [4,5-d]pyrimidin-2-yl)acetate (18) 
Fusion of 3 (0.01 mol) with ethyl cyanoacetate (0.01 mol) for 2 hr in an oil-bath at 150 oC gave a pale yellow 
product which recrystallized from ethanol to give 18. 
Yield (72%); m.p. 275 oC; IR (KBr): ν/cm-1= 3340 (OH), 1730 cm-1 (ester CO); 1H-NMR (DMSO-d6) δ (ppm): 
1.20 (t, 3H, CH2CH3), 4.10 (s, 2H, CH2), 4.20 (q, 2H, CH2CH3), 7.10-7.80 (m, 8H, Ar-H)CH3), 9.24 (s, 1H, C2-H 
pyridine); MS (EI, 70 eV): m/z (%) = 387 (M+, 100). Anal. Calcd. for C21H17N5O3 (387.40): C, 65.11; H, 4.42; N, 
18.08%. Found: C, 65.00; H, 4.19; N, 17.85%. 
3.1.15. Synthesis of 7-phenyl-5-(pyridin-3-yl)-2-(trichloromethyl)pyrimido[4,5-d]pyrimidin-4(3H)-one (19) 
A solution of 3 (0.005 mol) in ethanol (20 ml) was refluxed with trichloroacetonitrile (0.005 mol) for 3 hr and 
evaporated in vacuo. The residue was triturated with ethanol and the resulting solid product was collected by 
filtration and crystallized from ethanol to give 19. 
Yield (53%); m.p. 233 oC; IR (KBr): ν/cm-1= 3310 (NH), 1680 (CO), 760 (C-Cl); 1H-NMR (DMSO-d6) δ (ppm): 
7.50-8.60 (m, 8H, Ar-H), 9.24 (s, 1H, C2-H pyridine), 12.10 (s, 1H, NH); MS (EI, 70 eV): m/z (%) = 417 (M+, 
95). Anal. Calcd. for C18H10Cl3N5O (418.66): C, 51.64; H, 2.41; N, 16.73%. Found: C, 51.41; H, 2.31; N, 
16.66%. 
3.1.16. Synthesis of 7-phenyl-5-(pyridin-3-yl) -2-thioxo-2,3-dihydropyrimido [4,5-d]pyrimidin-4(1H)-one (20) 
A solution of 2 (0.005 mol) in acetone (20 ml) was stirred at room temperature with phenyl isothiocyanate (0.005 
mol) for 0.5 hr. The solid product was collected and crystallized from ethanol to give 20. 
Yield (62%); m.p. 219 oC; IR (KBr): ν/cm-1= 1700 (NH), 1595 (C=C), 1300 (C=S); 1H-NMR (DMSO-d6) δ 
(ppm): 7.35-8.57 (m, 8H, Ar-H), 9.24 (s, 1H, C2-H pyridine), 10.20 (s, 1H, NH), 12.10 (s, 1H, NH); MS (EI, 70 
eV): m/z (%) = 333 (M+, 100). Anal. Calcd. for C17H11N5OS (333.37): C, 67.47; H, 3.69; N, 17.10%. Found: C, 
67.35; H, 3.45; N, 16.85%. 
3.2. Antimicrobial evaluation 
The disks of Whatman filter paper were prepared with standard size (5.0 mm diameter) and kept into 1.0 Oz 
screw capped wide mouthed containers for sterilization. These bottles are kept into hot air oven at temperature of 
150°C. Then, the standard sterilized filter paper disks impregnated with a solution of the test compound in DMF 
(1 mg/mL) were placed on nutrient agar plate seeded with the appropriate test organism in triplicates. Standard 
concentrations of 106 CFU/mL (Colony Forming U/mL) and 104 CFU/mL were used for antibacterial and 
antifungal assay, respectively. Pyrex glass Petri dishes (9 cm in diameter) were used and two disks of filter paper 
were inoculated in each plate. The utilized test organisms were: B. subtilis and B. thuringiensis as examples of 
Gram-positive bacteria and E. coli and P. aeruginosa as examples of Gram-negative bacteria. They were also 
evaluated for their in vitro antifungal potential against F. oxysporum and B. fabae fungal strains. 
Chloramphenicol, cephalothin and cycloheximide were used as standard antibacterial and antifungal agents, 
respectively. DMF alone was used as control at the same above-mentioned concentration and due this there was 
no visible change in bacterial growth. The plates were incubated at 37°C for 24 h for bacteria and for 48 h for 
fungi. Compounds that showed significant growth inhibition zones (> 14 mm) using the twofold serial dilution 
technique, were further evaluated for their minimal inhibitory concentrations (MICs). 
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3.3. Minimal inhibitory concentration (MIC) measurement 
The microdilution susceptibility test in Müller-Hinton Broth (Oxoid) and Sabouraud Liquid Medium (Oxoid) 
were used for the determination of antibacterial and antifungal activity, respectively. Stock solutions of the tested 
compounds, chloramphenicol, cephalothin and cycloheximide were prepared in DMF at concentration of 1000 
mg/mL. Each stock solution was diluted with standard method broth (Difco) to prepare serial twofold dilutions 
in the range of 500-3.125 mg/mL 10 mL of the broth containing about 106 CFU/mL of test bacteria was added to 
each well of 96-well microtiter plate. The sealed microplates were incubated at 37°C for 24 h for antibacterial 
activity and at 37°C for 48 h for antifungal activity in a humid chamber. At the end of the incubation period, the 
minimal inhibitory concentrations (MIC) values were recorded as the lowest concentrations of the substance that 
had no visible turbidity. Control experiments with DMF and uninoculated media were run parallel to the test 
compounds under the same conditions. The substance that had no visible turbidity. Control experiments with 
DMF and uninoculated media were run parallel to the test compounds under the same conditions.  
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